Skip to main content
. 2010 May 19;1(1):34–42. doi: 10.18632/oncotarget.106

Fig. 1.

Fig. 1

Kinetics of peripheral blood neutrophil count, platelet count, and hemoglobin level during the treatment period. The evolution of peripheral blood neutrophil count (/mm3), platelet count (/mm3), and hemoglobin level (g/dL) is shown in the 34 patients who may receive the planned 6 treatment cycles, according to the response (15 CR + PR patients versus 19 non-responding patients).